| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.99.16.2079 |
| P698 | PubMed publication ID | 10217645 |
| P50 | author | Giovanna Liuzzo | Q57079763 |
| P2093 | author name string | Dinarello CA | |
| Fantuzzi G | |||
| Caligiuri G | |||
| Biasucci LM | |||
| Maseri A | |||
| Ginnetti F | |||
| Rebuzzi AG | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| anakinra | Q415411 | ||
| unstable angina | Q2032041 | ||
| hospitalization | Q3140971 | ||
| P304 | page(s) | 2079-2084 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events | |
| P478 | volume | 99 |
| Q36155188 | A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity |
| Q35907508 | A flame burning within |
| Q37892623 | A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis |
| Q74574025 | Activation of CD14 on circulating monocytes in patients with acute coronary syndrome |
| Q44283440 | Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men. |
| Q79212082 | Age-Specific Analysis of Normal Cytokine Levels in Healthy Infants |
| Q59326346 | Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis |
| Q37452257 | An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. |
| Q58326155 | Anakinra treatment in drug-resistant Behcet’s disease: a case series |
| Q89819876 | Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis |
| Q50253399 | Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. |
| Q51184443 | Association between local interleukin-6 levels and slow flow/microvascular dysfunction. |
| Q35654987 | Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction |
| Q59326294 | Asymptomatic bacteriuria in elderly humans is associated with increased levels of circulating TNF receptors and elevated numbers of neutrophils |
| Q37118553 | Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones |
| Q27004493 | Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity |
| Q37207351 | Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future. |
| Q37500635 | Biomarkers in cardiovascular medicine |
| Q38008700 | Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. |
| Q34369793 | C-Reactive Protein and cardiac troponin for early risk stratification in patients with acute coronary syndromes |
| Q34369787 | C-Reactive Protein and secondary prevention of coronary events. |
| Q28195425 | C-reactive protein and other inflammatory risk markers in acute coronary syndromes |
| Q43580590 | C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris |
| Q36359877 | Cardiac biomarkers: a contemporary status report |
| Q43129813 | Cardiac release and kinetics of cytokines after elective bare metal coronary stenting |
| Q21246039 | Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof |
| Q34563216 | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment |
| Q34767602 | Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina |
| Q43098741 | Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel |
| Q46270796 | Changes in serum interleukin-6, C-reactive protein and thrombomodulin levels under periodontal ultrasonic debridement |
| Q52867371 | Chemokine RANTES is increased at early stages of coronary artery disease. |
| Q45118470 | Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation |
| Q39418140 | Clinical Laboratory Tools to Diagnose Inflammation |
| Q57419400 | Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels |
| Q51812873 | Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting |
| Q33802181 | Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis. |
| Q51012096 | Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. |
| Q35624602 | Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity. |
| Q38292434 | Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. |
| Q82969420 | Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease |
| Q45034594 | Effect of withdrawal of statin on C-reactive protein |
| Q36381540 | Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers |
| Q37873559 | Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection |
| Q43172658 | Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use. |
| Q61928027 | Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality |
| Q35379833 | Elevated concentrations of macrophage colony stimulating factor predict worse in-hospital prognosis in unstable angina |
| Q51068359 | Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. |
| Q92754538 | Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling |
| Q43741286 | FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834. |
| Q50626205 | Fear of dying and inflammation following acute coronary syndrome. |
| Q36700001 | Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease |
| Q35523321 | Helper T cells and atherosclerosis: the cytokine web |
| Q40728614 | High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy |
| Q33604320 | Hostility and physiological responses to laboratory stress in acute coronary syndrome patients |
| Q28190586 | Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial |
| Q51808544 | Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response |
| Q77111489 | Increased circulating monocyte activation in patients with unstable coronary syndromes |
| Q44883715 | Increased risk of cardiovascular events in patients with herpes zoster: a population-based study |
| Q81557507 | Inflammation a possible link between economical stress and coronary heart disease |
| Q37252413 | Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans |
| Q34532851 | Inflammation in acute coronary syndromes. |
| Q35137720 | Inflammation in sleep apnea: an update. |
| Q60492174 | Inflammatory Cytokines Imbalance in the Very Early Phase of Acute Coronary Syndrome: Correlations with Angiographic Findings and In-Hospital Events |
| Q34941391 | Inflammatory bio-markers and cardiovascular risk prediction |
| Q37698323 | Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. |
| Q38722298 | Inflammatory cytokines in atherosclerosis: current therapeutic approaches. |
| Q39658472 | Inflammatory cytokines provide limited early prognostic information in emergency department patients with suspected myocardial ischemia |
| Q48426795 | Inflammatory cytokines, socioeconomic status, and acute stress responsivity |
| Q38355385 | Inflammatory markers in ST-elevation acute myocardial infarction |
| Q44596967 | Inflammatory markers increase following exposure to radiographic contrast media |
| Q38788685 | Inflammatory processes in cardiovascular disease: a route to targeted therapies |
| Q92869550 | Influence of Interleukin-6 (IL-6) Promoter Gene Polymorphisms (-174G>C, -572G>C, and -597G>A) on IL-6 Plasma Levels and Their Impact in the Development of Acute Ischemic Stroke in Young Indians |
| Q41871311 | Interleukin 1-β, interleukin-1 receptor antagonist, and interleukin 18 in children with acute spontaneous urticaria |
| Q37193601 | Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study |
| Q37872553 | Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies |
| Q46470171 | Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction. |
| Q73316912 | Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease |
| Q59797596 | Interleukin-6 Level among Shift and Night Workers in Japan: Cross-Sectional Analysis of the J-HOPE Study |
| Q40675496 | Interleukin-6 and acute coronary syndrome. |
| Q34544863 | Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes |
| Q89980650 | Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking |
| Q36532549 | Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study). |
| Q33727578 | LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathway |
| Q33260505 | Levels of acute phase proteins remain stable after ischemic stroke |
| Q82230801 | Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability |
| Q35005089 | Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition |
| Q40524480 | Mild acute inflammatory stimulation induces transient negative mood |
| Q47390373 | Monocyte cytokine production, systemic inflammation and cardiovascular disease in very elderly men and women: the Framingham Heart Study |
| Q44004395 | Morning cortisol production in coronary heart disease patients |
| Q36762903 | Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus |
| Q51948865 | Natural killer cell and proinflammatory cytokine responses to mental stress: associations with heart rate and heart rate variability. |
| Q43899359 | Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms. |
| Q28218040 | Novel serologic markers of cardiovascular risk |
| Q34427727 | Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients. |
| Q33723960 | Pathogenic mechanisms in unstable angina |
| Q33183129 | Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. |
| Q51372441 | Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. |
| Q35549761 | Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions |
| Q24683609 | Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina |
| Q83641277 | Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy |
| Q37067156 | Pre-Operative Cognitive Functioning and Inflammatory and Neuroendocrine Responses to Cardiac Surgery |
| Q37104249 | Predictors of vitamin B6 and folate concentrations in older persons: the InCHIANTI study |
| Q36624223 | Present and future biochemical markers for detection of acute coronary syndrome |
| Q78512141 | Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina |
| Q77616409 | Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention |
| Q73038824 | Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris |
| Q81307125 | Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock |
| Q51279094 | Proinflammatory cytokines remain elevated despite long-term remission in Cushing's disease: a prospective study. |
| Q43593143 | Psychosocial and reported inflammatory disease correlates of self-reported heart disease in women from South of Israel. |
| Q37422190 | Pulmonary responses to subacute ozone exposure in obese vs. lean mice |
| Q33467558 | Quick identification of acute chest pain patients study (QICS). |
| Q52031450 | Rapid assessment of patients with non-ST-segment elevation acute chest pain: troponins, inflammatory markers, or perfusion imaging? |
| Q101126059 | Reduced concentrations of the B cell cytokine Interleukin 38 are associated with cardiovascular disease risk in overweight subjects |
| Q44346396 | Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors |
| Q37726127 | Relationship between site of myocardial infarction, left ventricular function and cytokine levels in patients undergoing coronary artery surgery |
| Q51411732 | Release of mitochondrial DNA correlates with peak inflammatory cytokines in patients with acute myocardial infarction. |
| Q34445660 | Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines. |
| Q37429079 | Roles of IL-6-gp130 Signaling in Vascular Inflammation |
| Q37104446 | Sarcopenic obesity and inflammation in the InCHIANTI study |
| Q77763296 | Selected cytokines and soluble forms of cytokine receptors in coronary artery disease |
| Q73128774 | Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure |
| Q37531480 | Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease |
| Q60492166 | Subacute Inflammatory Activation in Subjects with Acute Coronary Syndrome and Left Ventricular Dysfunction |
| Q33951802 | Symptom expectations and delay in acute myocardial infarction patients |
| Q62011092 | Systemic inflammation in unstable angina is the result of myocardial necrosis |
| Q38531965 | Systemic inflammatory response following acute myocardial infarction |
| Q34979088 | Systemic inflammatory response induced by particulate matter air pollution: the importance of bone-marrow stimulation |
| Q36283482 | T cells and cytokines in atherogenesis. |
| Q27009347 | Targeting interleukin-1 in heart disease |
| Q48665358 | Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction |
| Q92256319 | Testosterone replacement therapy and cardiovascular risk |
| Q54752467 | The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. |
| Q35738921 | The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases |
| Q22252405 | The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes |
| Q41636614 | The Roles of Hypoxia Signaling in the Pathogenesis of Cardiovascular Diseases |
| Q73095290 | The continuously evolving problems of acute ischemic coronary syndromes |
| Q35059517 | The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study |
| Q30662120 | The prognostic value of small-sized platelet aggregates in unstable angina: detection by a novel laser-light scattering method |
| Q33351796 | The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation |
| Q35990267 | The relationship between plasma carotenoids and depressive symptoms in older persons |
| Q36059484 | The role of interleukin 6 in the pathophysiology of rheumatoid arthritis |
| Q38777212 | The role of the cytokine network in psychological stress |
| Q37549334 | The rs2228145 polymorphism in the interleukin-6 receptor and its association with long-term prognosis after myocardial infarction in a pilot study |
| Q42407082 | The ubiquitous interleukin-6: a time for reappraisal |
| Q37462533 | Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor |
| Q21296645 | Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases |
| Q44004556 | Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration |
| Q38318626 | Trans-system mechanisms against ischemic myocardial injury |
| Q28344629 | Tumor necrosis factor receptor levels are associated with carotid atherosclerosis |
| Q35380078 | Use of cardiac rehabilitation among patients following coronary artery bypass surgery |
| Q44213967 | Usefulness of elevated levels of soluble vascular cell adhesion molecule-1 in predicting in-hospital prognosis in patients with unstable angina pectoris |
| Q30319434 | Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms |
| Q38639570 | Where Does Inflammation Fit? |
| Q33849338 | Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent |
| Q73471690 | [Circadian variations in proinflammatory cytokine concentrations in acute myocardial infarction] |
| Q53868946 | [Interleukin-10 and coronary disease]. |
Search more.